Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial

Scantamburlo G.; Hansenne M.; Geenen V.; Legros J. J.; Ansseau M.

首页> 外文期刊>European psychiatry: the journal of the Association of European Psychiatrists >Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial

【24h】

Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial

机译：依他普仑额外鼻内催产素可改善耐药性抑郁症的抑郁症状：一项公开试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim of this open trial was to assess the antidepressant/anxiolytic effects of oxytocin used as an adjunct to antidepressant in treatment-resistant depression. Fourteen patients, who have not responded to 40 mg of escitalopram, received intranasal synthetic oxytocin during 4 weeks, in association with antidepressant. This is the first open trial study suggesting OT in association with escitalopram significantly reduced scores on Hamilton Depression Rating Scale. (C) 2014 Elsevier Masson SAS. All rights reserved.

著录项

来源
《European psychiatry: the journal of the Association of European Psychiatrists》 |2015年第1期|共4页
作者
Scantamburlo G.; Hansenne M.; Geenen V.; Legros J. J.; Ansseau M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类精神病学;
关键词
Major depression; Intranasal oxytocin; Anxiety;

机译：重度抑郁症;鼻内催产素;焦虑症;

相似文献

外文文献
中文文献
专利

1. Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial [J] . Scantamburlo G., Hansenne M., Geenen V., European psychiatry: the journal of the Association of European Psychiatrists . 2015,第1期

机译：依他普仑额外鼻内催产素可改善耐药性抑郁症的抑郁症状：一项公开试验
2. Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial [J] . Ding Ning, Li Zhiqiang, Liu Zengxun Neuroscience Letters: An International Multidisciplinary Journal Devoted to the Rapid Publication of Basic Research in the Brain Sciences . 2018,第期

机译：EscitalOPRAM增强改善治疗抗性精神分裂症患者的阴性症状 - 一种随机对照试验
3. A pragmatic pilot randomized trial to investigate the effectiveness of behavioural activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial protocol [J] . Zainab Samaan, Kathryn Litke, Kathleen McCabe, Pilot and Feasibility Studies . 2015,第1期

机译：一项实用的试验性随机试验，旨在研究行为激活组疗法在减轻抑郁症患者的抑郁症状和改善生活质量方面的有效性：BRAVE试验性试验方案
4. Production Acceleration or Additional Recovery? A Look Back at Three Published Field Trials to Determine the Long Term Benefits of Improved Fracture Treatments [C] . K. Blackwood, P. Handren, M. Chapman Society of Petroleum Engineers Unconventional Gas Conference . 2011

机译：生产加速或额外的恢复？回顾三个公布的现场试验，以确定改善骨折治疗的长期益处
5. A Randomized, Double-Blind, Placebo-Controlled Crossover Trial Evaluating the Effect of Intranasal Insulin on Cognition and Emotional Processing in Individuals with Treatment-Resistant Major Depressive Disorder. [D] . Cha, Danielle Soh-Young. 2016

机译：一项随机，双盲，安慰剂对照的交叉试验评估了鼻内胰岛素对难治性重度抑郁症患者认知和情绪加工的影响。
6. A pragmatic pilot randomized trial to investigate the effectiveness of behavioural activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial protocol [O] . Zainab Samaan, Kathryn Litke, Kathleen McCabe, 2015

机译：一项实用的试验性随机试验旨在探讨行为激活组疗法在减轻抑郁症患者的抑郁症状和改善生活质量方面的有效性：BRAVE试验性试验方案
7. A pragmatic pilot randomized trial to investigate the effectiveness of behavioural activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial protocol [O] . Zainab Samaan, Kathryn Litke, Kathleen McCabe, 2015

机译：一项实用的试验性随机试验，旨在探讨行为激活组疗法在减轻抑郁症患者的抑郁症状和改善生活质量方面的有效性：BRAVE试验性试验方案

Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial

摘要

著录项

相似文献

相关主题

期刊订阅